By expenditures
| Name | Title | Type |
|---|---|---|
| Rodolfo D. Sanchez | Executive Director | Auditee |
| Jaime Rumbaoa | PRINCIPAL | Auditee |
| Scott Eliason | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 402501 | 2024 | 2026-05-28 | JARAMILLO ACCOUNTING GROUP | $5.15M |
| 401962 | 2025 | 2026-05-21 | JARAMILLO ACCOUNTING GROUP | $5.87M |
| 355304 | 2024 | 2025-05-01 | Jaramillo Accounting Group LLC | $6.00M |
| 355303 | 2023 | 2025-05-01 | Axiom CPAS and Business Advisors LLC | $4.88M |
| 17781 | 2022 | 2023-09-29 | Axiom CPAS and Business Advisors LLC | $4.80M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 402501 | 2024 | 2026-05-28 | 1215936 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215935 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215934 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215933 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215932 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215931 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215930 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215929 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215928 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215927 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215926 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215925 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215924 | 2024-004 | Material Weakness | Yes | P |
| 402501 | 2024 | 2026-05-28 | 1215923 | 2024-003 | Material Weakness | Yes | B |
| 402501 | 2024 | 2026-05-28 | 1215922 | 2024-003 | Material Weakness | Yes | B |
| 402501 | 2024 | 2026-05-28 | 1215921 | 2024-003 | Material Weakness | Yes | B |
| 402501 | 2024 | 2026-05-28 | 1215920 | 2024-003 | Material Weakness | Yes | B |
| 402501 | 2024 | 2026-05-28 | 1215919 | 2024-003 | Material Weakness | Yes | B |
| 402501 | 2024 | 2026-05-28 | 1215918 | 2024-003 | Material Weakness | Yes | B |
| 402501 | 2024 | 2026-05-28 | 1215917 | 2024-003 | Material Weakness | Yes | B |
| 355304 | 2024 | 2025-05-01 | 1135486 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 1135485 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 1135484 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 1135483 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 1135482 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 1135481 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 559044 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 559043 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 559042 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 559041 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 559040 | 2024-001 | Significant Deficiency | - | B |
| 355304 | 2024 | 2025-05-01 | 559039 | 2024-001 | Significant Deficiency | - | B |